Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
Haploidentical Stem Cell Transplantation Using PTCY Platform in Paediatric Patients with High-Risk Neuroblastoma | Synapse
March 3, 2026
Haploidentical Stem Cell Transplantation Using PTCY Platform in Paediatric Patients with High-Risk Neuroblastoma
CJ
Cristina Jercan
AB
Ana Maria Bica
IA
Irina Avramescu
Carol Davila University of Medicine and Pharmacy
See all
Key Points
Outcomes indicate a significant improvement in pediatric patients after haploidentical stem cell transplantation.
The analysis observed a 30% increase in survival rates compared to previous modalities.
Haploidentical stem cell transplantation was conducted using the PTCY platform to mitigate graft-versus-host disease.
These findings suggest the PTCY method may lead to enhanced treatments for high-risk neuroblastoma cases.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Jercan et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76022c6e9836116a2c95a
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.904